68 related articles for article (PubMed ID: 12966601)
21. Cancer Risk in a Large Inception Systemic Lupus Erythematosus Cohort: Effects of Demographic Characteristics, Smoking, and Medications.
Bernatsky S; Ramsey-Goldman R; Urowitz MB; Hanly JG; Gordon C; Petri MA; Ginzler EM; Wallace DJ; Bae SC; Romero-Diaz J; Dooley MA; Peschken CA; Isenberg DA; Rahman A; Manzi S; Jacobsen S; Lim SS; van Vollenhoven R; Nived O; Kamen DL; Aranow C; Ruiz-Irastorza G; Sánchez-Guerrero J; Gladman DD; Fortin PR; Alarcón GS; Merrill JT; Kalunian KC; Ramos-Casals M; Steinsson K; Zoma A; Askanase A; Khamashta MA; Bruce I; Inanc M; Clarke AE
Arthritis Care Res (Hoboken); 2021 Dec; 73(12):1789-1795. PubMed ID: 32813314
[TBL] [Abstract][Full Text] [Related]
22. The relationship between cancer and medication exposure in patients with systemic lupus erythematosus: a nested case-control study.
Guo J; Ren Z; Li J; Li T; Liu S; Yu Z
Arthritis Res Ther; 2020 Jun; 22(1):159. PubMed ID: 32586407
[TBL] [Abstract][Full Text] [Related]
23. Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus.
Vincent FB; Kandane-Rathnayake R; Koelmeyer R; Harris J; Hoi AY; Mackay F; Morand EF
Lupus Sci Med; 2020 Jun; 7(1):. PubMed ID: 32546562
[TBL] [Abstract][Full Text] [Related]
24. Treat-to-target strategies aiming at additional ultrasound remission is associated with better control of disease activity and less flare in rheumatoid arthritis.
Geng Y; Wang L; Zhang X; Ji L; Deng X; Zhang Z
Clin Rheumatol; 2021 Jan; 40(1):113-121. PubMed ID: 32514681
[TBL] [Abstract][Full Text] [Related]
25. High disease activity status suggests more severe disease and damage accrual in systemic lupus erythematosus.
Koelmeyer R; Nim HT; Nikpour M; Sun YB; Kao A; Guenther O; Morand E; Hoi A
Lupus Sci Med; 2020 May; 7(1):. PubMed ID: 32467293
[TBL] [Abstract][Full Text] [Related]
26. Integrated analysis of lncRNA, miRNA and mRNA expression profiling in patients with systemic lupus erythematosus.
Zhang Q; Liang Y; Yuan H; Li S; Wang JB; Li XM; Tao JH; Pan HF; Ye DQ
Arch Med Sci; 2019 Jul; 15(4):872-879. PubMed ID: 31360182
[TBL] [Abstract][Full Text] [Related]
27. Anti-RNP/Sm antibodies in patients with systemic lupus erythematosus and its role in thrombosis: a case-control study.
Zamora-Medina MDC; Hinojosa-Azaola A; Nuñez-Alvarez CA; Vargas-Ruiz AG; Romero-Diaz J
Clin Rheumatol; 2019 Mar; 38(3):885-893. PubMed ID: 30515663
[TBL] [Abstract][Full Text] [Related]
28. The association between 10-year fracture risk by FRAX and osteoporotic fractures with disease activity in patients with rheumatoid arthritis.
Phuan-Udom R; Lektrakul N; Katchamart W
Clin Rheumatol; 2018 Oct; 37(10):2603-2610. PubMed ID: 30039267
[TBL] [Abstract][Full Text] [Related]
29. Clustered multistate models with observation level random effects, mover-stayer effects and dynamic covariates: modelling transition intensities and sojourn times in a study of psoriatic arthritis.
Yiu S; Farewell VT; Tom BDM
J R Stat Soc Ser C Appl Stat; 2018 Feb; 67(2):481-500. PubMed ID: 29371746
[TBL] [Abstract][Full Text] [Related]
30. Cardiovascular risk profiles in a lupus cohort: what do different calculators tell us?
Boulos D; Koelmeyer RL; Morand EF; Hoi AY
Lupus Sci Med; 2017; 4(1):e000212. PubMed ID: 29214035
[TBL] [Abstract][Full Text] [Related]
31. Prevalence and features of metabolic syndrome in childhood-onset systemic lupus erythematosus.
Sinicato NA; Postal M; de Oliveira Peliçari K; Rittner L; Marini R; Appenzeller S
Clin Rheumatol; 2017 Jul; 36(7):1527-1535. PubMed ID: 28424906
[TBL] [Abstract][Full Text] [Related]
32. Protein Phosphatase 5 Contributes to the Overexpression of Epigenetically Regulated T-Lymphocyte Genes in Patients with Lupus.
Patel D; Gorelik G; Richardson B
Lupus (Los Angel); 2016 Dec; 1(3):. PubMed ID: 28239687
[TBL] [Abstract][Full Text] [Related]
33. Independent association of glucocorticoids with damage accrual in SLE.
Apostolopoulos D; Kandane-Rathnayake R; Raghunath S; Hoi A; Nikpour M; Morand EF
Lupus Sci Med; 2016; 3(1):e000157. PubMed ID: 27933196
[TBL] [Abstract][Full Text] [Related]
34. Progression of noncalcified and calcified coronary plaque by CT angiography in SLE.
Khan A; Arbab-Zadeh A; Kiani AN; Magder LS; Petri M
Rheumatol Int; 2017 Jan; 37(1):59-65. PubMed ID: 27882428
[TBL] [Abstract][Full Text] [Related]
35. Breast cancer in systemic lupus.
Bernatsky S; Ramsey-Goldman R; Petri M; Urowitz MB; Gladman DD; Fortin PR; Ginzler E; Romero-Diaz J; Peschken C; Jacobsen S; Hanly JG; Gordon C; Nived O; Yelin EH; Isenberg D; Rahman A; Bae SC; Joseph L; Witte T; Ruiz-Irastorza G; Aranow C; Kamen D; Sturfeldt G; Foulkes WD; Hansen JE; St Pierre Y; Raymer PC; Tessier-Cloutier B; Clarke AE
Lupus; 2017 Mar; 26(3):311-315. PubMed ID: 27687028
[TBL] [Abstract][Full Text] [Related]
36. Development and validation of a simple lupus severity index using ACR criteria for classification of SLE.
Bello GA; Brown MA; Kelly JA; Thanou A; James JA; Montgomery CG
Lupus Sci Med; 2016; 3(1):e000136. PubMed ID: 27026812
[TBL] [Abstract][Full Text] [Related]
37. Direct medical costs and their predictors in South Korean patients with systemic lupus erythematosus.
Park SY; Joo YB; Shim J; Sung YK; Bae SC
Rheumatol Int; 2015 Nov; 35(11):1809-15. PubMed ID: 26254885
[TBL] [Abstract][Full Text] [Related]
38. Systemic Lupus Erythematosus Patients Exhibit Reduced Expression of CLEC16A Isoforms in Peripheral Leukocytes.
Tam RC; Lee AL; Yang W; Lau CS; Chan VS
Int J Mol Sci; 2015 Jun; 16(7):14428-40. PubMed ID: 26121298
[TBL] [Abstract][Full Text] [Related]
39. Obesity and cytokines in childhood-onset systemic lupus erythematosus.
Sinicato NA; Postal M; Peres FA; Peliçari Kde O; Marini R; dos Santos Ade O; Ramos CD; Appenzeller S
J Immunol Res; 2014; 2014():162047. PubMed ID: 24741576
[TBL] [Abstract][Full Text] [Related]
40. Clinical associations of serum interleukin-17 in systemic lupus erythematosus.
Vincent FB; Northcott M; Hoi A; Mackay F; Morand EF
Arthritis Res Ther; 2013 Aug; 15(4):R97. PubMed ID: 23968496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
